genedrive plc D6M.F Stock
genedrive plc Price Chart
genedrive plc D6M.F Financial and Trading Overview
| genedrive plc stock price | 0.05 EUR |
| Previous Close | 0.15 EUR |
| Open | 0.14 EUR |
| Bid | 0.19 EUR x N/A |
| Ask | 0.25 EUR x N/A |
| Day's Range | 0.14 - 0.14 EUR |
| 52 Week Range | 0.03 - 0.48 EUR |
| Volume | 5K EUR |
| Avg. Volume | 437 EUR |
| Market Cap | 21.47M EUR |
| Beta (5Y Monthly) | 0.421072 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
D6M.F Valuation Measures
| Enterprise Value | 10.54M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 315.72827 |
| Price/Book (mrq) | 3.7567568 |
| Enterprise Value/Revenue | 154.973 |
| Enterprise Value/EBITDA | -1.939 |
Trading Information
genedrive plc Stock Price History
| Beta (5Y Monthly) | 0.421072 |
| 52-Week Change | -25.69% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.48 EUR |
| 52 Week Low | 0.03 EUR |
| 50-Day Moving Average | 0.2 EUR |
| 200-Day Moving Average | 0.14 EUR |
D6M.F Share Statistics
| Avg. Volume (3 month) | 437 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 99.05M |
| Float | 91.3M |
| Short Ratio | N/A |
| % Held by Insiders | 60.90% |
| % Held by Institutions | 4.19% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8091.17% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -48.86% |
| Return on Equity (ttm) | -80.25% |
Income Statement
| Revenue (ttm) | 68K EUR |
| Revenue Per Share (ttm) | 0.001 EUR |
| Quarterly Revenue Growth (yoy) | 950.00% |
| Gross Profit (ttm) | -3822000 EUR |
| EBITDA | -5436000 EUR |
| Net Income Avi to Common (ttm) | -4559000 EUR |
| Diluted EPS (ttm) | -0.05 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.08M EUR |
| Total Cash Per Share (mrq) | 0.02 EUR |
| Total Debt (mrq) | 313K EUR |
| Total Debt/Equity (mrq) | 9.06 EUR |
| Current Ratio (mrq) | 3.364 |
| Book Value Per Share (mrq) | 0.037 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4116000 EUR |
| Levered Free Cash Flow (ttm) | -2943875 EUR |
Profile of genedrive plc
| Country | Germany |
| State | N/A |
| City | Manchester |
| Address | The CTF Building |
| ZIP | M13 9XX |
| Phone | 44 16 1989 0245 |
| Website | https://www.genedriveplc.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 40 |
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, which incorporates various user-led improvements to its small, patented gene amplification platform for ease of use in time critical situations, and to simplify workflow, as well as for professional use in emergency healthcare settings. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for targeting various pathogens in the defense applications; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive COV19-ID Kit, an innovative rapid point-of care molecular test for COVID-19. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.
Q&A For genedrive plc Stock
What is a current D6M.F stock price?
genedrive plc D6M.F stock price today per share is 0.05 EUR.
How to purchase genedrive plc stock?
You can buy D6M.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for genedrive plc?
The stock symbol or ticker of genedrive plc is D6M.F.
Which industry does the genedrive plc company belong to?
The genedrive plc industry is Diagnostics & Research.
How many shares does genedrive plc have in circulation?
The max supply of genedrive plc shares is 225.52M.
What is genedrive plc Price to Earnings Ratio (PE Ratio)?
genedrive plc PE Ratio is now.
What was genedrive plc earnings per share over the trailing 12 months (TTM)?
genedrive plc EPS is -0.06 EUR over the trailing 12 months.
Which sector does the genedrive plc company belong to?
The genedrive plc sector is Healthcare.